ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

Normal Routines Dramatically Altered In Days Since Sept. 11 Terrorist Attacks.

September 21, 2001

Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography

February 14, 1997

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990

Cancer Meetings Listed For Next Three Months

September 20, 1996